The expression of urotensin II receptor (U2R) is up-regulated by interferon-γ

被引:38
作者
Birker-Robaczewska, M [1 ]
Boukhadra, C [1 ]
Studer, R [1 ]
Mueller, U [1 ]
Binkert, C [1 ]
Nayler, O [1 ]
机构
[1] Actelion Pharmaceut Ltd, CH-4123 Allschwil, Switzerland
关键词
GPR14; Urotensin-II; interferon-gamma; G protein-coupled receptor; inflammation; cytokine; signal transduction;
D O I
10.1081/RRS-120026972
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Urotensin-II (U-II) was identified as the natural ligand of the G protein-coupled receptor GPR14, which has been correspondingly renamed Urotensin-II receptor (U2R). The tissue distribution of U2R and the pharmacological effects of U-II suggest a novel neurohormonal system with potent cardiovascular effects. We he-c report the human rhabdomyosarcoma cell line TE-671 as the first natural and endogenous source of functional U2R in an immortalized cell line. In TE-671 cells, U-II stimulated extracellular signal regulated kinase phosphorylation and increased c-fos mRNA expression. Furthermore, we demonstrate that the expression of U2R mRNA and functional U-II high affinity binding sites are serum-responsive and that they are specifically up-regulated by interferon gamma (IFNgamma). We propose that IFNgamma contributes to the previously observed increase of U2R density in the heart tissue of congestive heart failure (CHF) patients and we suggest that U2R up-regulation, as a consequence of an inflammatory response, could lead to a clinical worsening of this disease.
引用
收藏
页码:289 / 305
页数:17
相关论文
共 38 条
  • [1] G-PROTEIN-COUPLED RECEPTOR GENES AS PROTOONCOGENES - CONSTITUTIVELY ACTIVATING MUTATION OF THE ALPHA-1B-ADRENERGIC RECEPTOR ENHANCES MITOGENESIS AND TUMORIGENICITY
    ALLEN, LF
    LEFKOWITZ, RJ
    CARON, MG
    COTECCHIA, S
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (24) : 11354 - 11358
  • [2] Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14
    Ames, RS
    Sarau, HM
    Chambers, JK
    Willette, RN
    Alyar, NV
    Romanic, AM
    Louden, CS
    Foley, JJ
    Sauermelch, CF
    Coatney, RW
    Ao, ZH
    Disa, J
    Holmes, SD
    Stadel, JM
    Martin, JD
    Liu, WS
    Glover, GI
    Wilson, S
    McNulty, DE
    Ellis, CE
    Elshourbagy, NA
    Shabon, U
    Trill, JJ
    Hay, DWP
    Ohlstein, EH
    Bergsma, DJ
    Douglas, SA
    [J]. NATURE, 1999, 401 (6750) : 282 - 286
  • [3] BARKER EL, 1994, J BIOL CHEM, V269, P11687
  • [4] Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord
    Coulouarn, Y
    Lihrmann, I
    Jegou, S
    Anouar, Y
    Tostivint, H
    Beauvillain, JC
    Conlon, JM
    Bern, HA
    Vaudry, H
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (26) : 15803 - 15808
  • [5] Congestive heart failure and expression of myocardial urotensin II
    Douglas, SA
    Tayara, L
    Ohlstein, EH
    Halawa, N
    Giaid, A
    [J]. LANCET, 2002, 359 (9322) : 1990 - 1997
  • [6] Douglas SA, 2000, CIRCULATION, V102, P113
  • [7] Human urotensin-II is a potent vasoactive peptide: Pharmacological characterization in the rat, mouse, dog and primate
    Douglas, SA
    Ashton, DJ
    Sauermelch, CF
    Coatney, RW
    Ohlstein, DH
    Ruffolo, MR
    Ohlstein, EH
    Aiyar, NV
    Willette, RN
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2000, 36 : S163 - S166
  • [8] Differential vasoconstrictor activity of human urotensin-II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey
    Douglas, SA
    Sulpizio, AC
    Piercy, V
    Sarau, HM
    Ames, RS
    Aiyar, NV
    Ohlstein, EH
    Willette, RN
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2000, 131 (07) : 1262 - 1274
  • [9] Molecular and pharmacological characterization of genes encoding urotensin-II peptides and their cognate G-protein-coupled receptors from the mouse and monkey
    Elshourbagy, NA
    Douglas, SA
    Shabon, U
    Harrison, S
    Duddy, G
    Sechler, JL
    Ao, ZH
    Maleeff, BE
    Naselsky, D
    Disa, J
    Aiyar, NV
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2002, 136 (01) : 9 - 22
  • [10] FUCHS D, 1993, EUR J CLIN CHEM CLIN, V31, P111